#elife — Public Fediverse posts

#Tunisia: A new #Elife Technology Centre, backed by #FTD, @KfW_int, #GIZ & @AFD_France, the 5th in Elife network, has opened in #SidiBouzid to equip young people with skills for jobs in digital, industrial & agricultural sectors, with an ambition of 1000 jobs annually. #TAP_En
(@TapNewsAgency)

https://nitter.net/TapNewsAgency/status/2066971396752687275#m

#Tunisia: A new #Elife Technology Centre, backed by #FTD, @KfW_int, #GIZ & @AFD_France, the 5th in Elife network, has opened in #SidiBouzid to equip young people with skills for jobs in digital, industrial & agricultural sectors, with an ambition of 1000 jobs annually. #TAP_En
(@TapNewsAgency)

https://nitter.net/TapNewsAgency/status/2066971396752687275#m

New #elife paper dropped:

C. C. Damphousse, O. L. Calvin, A. D. Redish (2026) Hippocampal representations differentiate reactive and anticipatory responses during foraging under threat. eLife. 15:RP111762
https://doi.org/10.7554/eLife.111762.1

1/n

New #elife paper dropped:

C. C. Damphousse, O. L. Calvin, A. D. Redish (2026) Hippocampal representations differentiate reactive and anticipatory responses during foraging under threat. eLife. 15:RP111762
https://doi.org/10.7554/eLife.111762.1

1/n

I like @eLife but it's a bit annoying to have "figure supplements" that are only accessible on the online version, by clicking , and for some reason are not in the PDF.. why??

#eLife #AcademicChatter

I like @eLife but it's a bit annoying to have "figure supplements" that are only accessible on the online version, by clicking , and for some reason are not in the PDF.. why??

#eLife #AcademicChatter

"Veronika Koren talks about pursuing a theory of neural coding that doesn’t fit a simple narrative, and the resilience it took to see it through."
https://elifesciences.org/inside-elife/75921c16/inside-discovery-where-theory-meets-biology

Q: "The first version of the article was described as "Incomplete" in the eLife Assessment. How did you feel about this, and what changes did you make to take that assessment to “Convincing”?"

A: "Our paper does not have a simple storyline but rather draws a somewhat intricate but deep link between a mathematical theory and the functioning of biological neural networks. We were worried that many journals would prefer a simpler "story", but estimated that eLife might be one that simultaneously enjoys an excellent reputation and where our results might be appreciated. [...] I was disappointed by the first assessment, because we omitted more detailed analyses to make the paper more focused. [...] the thorough reviews asked us to dig deeper, which we gladly did. I followed every comment of each reviewer with great attention, significantly reshaping the paper and making it more solid."

Indeed, at eLife we want the full enchilada. As it should be.

#neuroscience #eLife #eLifeAssessment

"Veronika Koren talks about pursuing a theory of neural coding that doesn’t fit a simple narrative, and the resilience it took to see it through."
https://elifesciences.org/inside-elife/75921c16/inside-discovery-where-theory-meets-biology

Q: "The first version of the article was described as "Incomplete" in the eLife Assessment. How did you feel about this, and what changes did you make to take that assessment to “Convincing”?"

A: "Our paper does not have a simple storyline but rather draws a somewhat intricate but deep link between a mathematical theory and the functioning of biological neural networks. We were worried that many journals would prefer a simpler "story", but estimated that eLife might be one that simultaneously enjoys an excellent reputation and where our results might be appreciated. [...] I was disappointed by the first assessment, because we omitted more detailed analyses to make the paper more focused. [...] the thorough reviews asked us to dig deeper, which we gladly did. I followed every comment of each reviewer with great attention, significantly reshaping the paper and making it more solid."

Indeed, at eLife we want the full enchilada. As it should be.

#neuroscience #eLife #eLifeAssessment

Reflecting on eLife's new publication model, 3 years in: "the most important thing we have learnt is that our new approach to publishing works. Authors, reviewers and editors routinely tell us that they have had a more constructive experience with the new approach."

https://elifesciences.org/articles/110392?_hsmi=98220609

Proud to be an eLife editor. eLife's publication model gets the best from everyone:
* from authors, who remain in control and can reply to reviewers without fear and without being overly apologetic or sycophantic;
* from reviewers, who engage constructively in a semi-anonymous way (they aren't anonymous neither to each other nor to the editors, all practicing scientists in their field), knowing that their comments are suggestions, not mandates for authors;
* and from editors, who don't have to deal with any nastiness from any party, everybody being far more relaxed that I've seen in any other journal, concentrating their efforts in the scientific content.

1/3

#eLife #ScientificPublishing

Reflecting on eLife's new publication model, 3 years in: "the most important thing we have learnt is that our new approach to publishing works. Authors, reviewers and editors routinely tell us that they have had a more constructive experience with the new approach."

https://elifesciences.org/articles/110392?_hsmi=98220609

Proud to be an eLife editor. eLife's publication model gets the best from everyone:
* from authors, who remain in control and can reply to reviewers without fear and without being overly apologetic or sycophantic;
* from reviewers, who engage constructively in a semi-anonymous way (they aren't anonymous neither to each other nor to the editors, all practicing scientists in their field), knowing that their comments are suggestions, not mandates for authors;
* and from editors, who don't have to deal with any nastiness from any party, everybody being far more relaxed that I've seen in any other journal, concentrating their efforts in the scientific content.

1/3

#eLife #ScientificPublishing

eLife is looking for an Early-Career Researcher Non-executive Director.

Deadline: TODAY, December 17th

"Joining the current members of the Board, the director will help determine eLife’s strategic priorities. We’re looking for a practicing early-career research scientist (postdoc or 0–5 years of running an independent research group) with proven leadership in open science and a strong desire to change the current system."

https://elifesciences.org/jobs/4ae0d5ee/non-executive-director-early-career-scientific

#ScientificPublishing #eLife

eLife is looking for an Early-Career Researcher Non-executive Director.

Deadline: TODAY, December 17th

"Joining the current members of the Board, the director will help determine eLife’s strategic priorities. We’re looking for a practicing early-career research scientist (postdoc or 0–5 years of running an independent research group) with proven leadership in open science and a strong desire to change the current system."

https://elifesciences.org/jobs/4ae0d5ee/non-executive-director-early-career-scientific

#ScientificPublishing #eLife

New article type just landed at eLife: “Replication Studies”

https://elife-rp.msubmit.net/html/elife-rp_author_instructions.html#types

#eLife #ScientificPublishing

New article type just landed at eLife: “Replication Studies”

https://elife-rp.msubmit.net/html/elife-rp_author_instructions.html#types

#eLife #ScientificPublishing

@elduvelle @albertcardona @neuralreckoning

To me this question seems to be the issue of the #eLife journal hypothesis: they are providing reviews on preprints. They are basically post-preprint review (like #PubPeer), but unlike PubPeer, they still think (at least they talk of themselves as) a journal.

I think what #eLife and #PubPeer are doing is great. But they cannot be listed in one's CV as "refereed publications" in the way that other gatekept* journals are.

... which gets at the point @jonmsterling made about separating "preprints", "refereed publications" and "titles I'm thinking about writing" (in preparation) on one's CV.

It would be interesting to see how #eLife is still being treated as a "journal" on CVs and for grants and promotion.

BTW, in an earlier discussion, we agreed that one could list eLife papers in one's CV as long as one also included the eLife assessment on one's CV. Wanna bet these authors don't? 🤔

* Yes, I know eLife is gatekept by editors, but the door is opened based on "interesting", not based on "correct". (And, yes, there is evidence that the Glam journals do that as well, but they are at least ostensibly _claiming_ to only publish papers that are "correct".)

#ScientificPublishing

@elduvelle @albertcardona @neuralreckoning

To me this question seems to be the issue of the #eLife journal hypothesis: they are providing reviews on preprints. They are basically post-preprint review (like #PubPeer), but unlike PubPeer, they still think (at least they talk of themselves as) a journal.

I think what #eLife and #PubPeer are doing is great. But they cannot be listed in one's CV as "refereed publications" in the way that other gatekept* journals are.

... which gets at the point @jonmsterling made about separating "preprints", "refereed publications" and "titles I'm thinking about writing" (in preparation) on one's CV.

It would be interesting to see how #eLife is still being treated as a "journal" on CVs and for grants and promotion.

BTW, in an earlier discussion, we agreed that one could list eLife papers in one's CV as long as one also included the eLife assessment on one's CV. Wanna bet these authors don't? 🤔

* Yes, I know eLife is gatekept by editors, but the door is opened based on "interesting", not based on "correct". (And, yes, there is evidence that the Glam journals do that as well, but they are at least ostensibly _claiming_ to only publish papers that are "correct".)

#ScientificPublishing

@albertcardona @jonny @pluralistic

It is also worth noting that it is completely legal to preprint all versions up to the final accepted version (but not the proofread / edited version*). So if you preprint everything you submit, there is no reason ever to pay "open access" APC charges.
* To my knowledge, no journal has fought an author on making that final version available on your lab website.

And, of course, there are now "prestige" journals (like #eLife) that are post-preprint review. (eLife is proof that the prestige problem [and the related inequity-driving cost-to-publish problem*] and the closed-access problem are different issues.)
* eLife costs $3000 to publish a paper.

BTW: Does APC stand for "author pays corporations"? 🫤

#AcademicPublishing

@albertcardona @jonny @pluralistic

It is also worth noting that it is completely legal to preprint all versions up to the final accepted version (but not the proofread / edited version*). So if you preprint everything you submit, there is no reason ever to pay "open access" APC charges.
* To my knowledge, no journal has fought an author on making that final version available on your lab website.

And, of course, there are now "prestige" journals (like #eLife) that are post-preprint review. (eLife is proof that the prestige problem [and the related inequity-driving cost-to-publish problem*] and the closed-access problem are different issues.)
* eLife costs $3000 to publish a paper.

BTW: Does APC stand for "author pays corporations"? 🫤

#AcademicPublishing

Nice to see that the #eLife model of 'Publish, Review, Curate' is catching on

https://mas.to/@ASAPbio/115388786984132931

Just got a reviewed preprint published @eLife :
https://doi.org/10.7554/eLife.108049

Based on this experience, publishing at #eLife is the best publication process I had so far: transparent, fast, thoughtful reviews and editorial consideration. If it's also easy to waive the APC fees for under-funded researchers, this makes it to me the most appealing journal in life sciences!

Oh the research question of the paper is about timing in decision making using our #HMP method on #EEG data. The assessment and reviews are very fair. We already have most results for the revision and it's looking very good as we identify further sensory and motor components using a more precise parametrization 🤩

Just got a reviewed preprint published @eLife :
https://doi.org/10.7554/eLife.108049

Based on this experience, publishing at #eLife is the best publication process I had so far: transparent, fast, thoughtful reviews and editorial consideration. If it's also easy to waive the APC fees for under-funded researchers, this makes it to me the most appealing journal in life sciences!

Oh the research question of the paper is about timing in decision making using our #HMP method on #EEG data. The assessment and reviews are very fair. We already have most results for the revision and it's looking very good as we identify further sensory and motor components using a more precise parametrization 🤩

✍️ New in #eLife: #CellSeg3D introduces #WNet3D, a self-supervised 3D #segmentation method for #microscopy data — no labels needed. Claims to outperform #Cellpose/#StarDist on 4 datasets. Includes #opensource plugin (#Napari) + full 3D annotated #cortex dataset. Will test it later.

🌍 https://elifesciences.org/articles/99848

#DeepLearning #Neuroscience

✍️ New in #eLife: #CellSeg3D introduces #WNet3D, a self-supervised 3D #segmentation method for #microscopy data — no labels needed. Claims to outperform #Cellpose/#StarDist on 4 datasets. Includes #opensource plugin (#Napari) + full 3D annotated #cortex dataset. Will test it later.

🌍 https://elifesciences.org/articles/99848

#DeepLearning #Neuroscience

✍️ New in #eLife: #CellSeg3D introduces #WNet3D, a self-supervised 3D #segmentation method for #microscopy data — no labels needed. Claims to outperform #Cellpose/#StarDist on 4 datasets. Includes #opensource plugin (#Napari) + full 3D annotated #cortex dataset. Will test it later.

🌍 https://elifesciences.org/articles/99848

#DeepLearning #Neuroscience

✍️ New in #eLife: #CellSeg3D introduces #WNet3D, a self-supervised 3D #segmentation method for #microscopy data — no labels needed. Claims to outperform #Cellpose/#StarDist on 4 datasets. Includes #opensource plugin (#Napari) + full 3D annotated #cortex dataset. Will test it later.

🌍 https://elifesciences.org/articles/99848

#DeepLearning #Neuroscience

✍️ New in #eLife: #CellSeg3D introduces #WNet3D, a self-supervised 3D #segmentation method for #microscopy data — no labels needed. Claims to outperform #Cellpose/#StarDist on 4 datasets. Includes #opensource plugin (#Napari) + full 3D annotated #cortex dataset. Will test it later.

🌍 https://elifesciences.org/articles/99848

#DeepLearning #Neuroscience

Excellent: "More than 100 institutions and funders worldwide have confirmed that research published in #eLife continues to be considered in hiring, promotion, and funding decisions, following the journal’s bold move to forgo its Journal Impact Factor."
https://elifesciences.org/for-the-press/bf74b86e/more-than-100-institutions-and-funders-confirm-recognition-of-elife-papers-signalling-support-for-open-science

PS: This is not just a step to support eLife, but a step to break the stranglehold of bad metrics in research assessment. For the same reason, it's a step toward more honest and less simplistic assessment.

#Academia #Assessment #JIF #Metrics #Universities
@academicchatter

Excellent: "More than 100 institutions and funders worldwide have confirmed that research published in #eLife continues to be considered in hiring, promotion, and funding decisions, following the journal’s bold move to forgo its Journal Impact Factor."
https://elifesciences.org/for-the-press/bf74b86e/more-than-100-institutions-and-funders-confirm-recognition-of-elife-papers-signalling-support-for-open-science

PS: This is not just a step to support eLife, but a step to break the stranglehold of bad metrics in research assessment. For the same reason, it's a step toward more honest and less simplistic assessment.

#Academia #Assessment #JIF #Metrics #Universities
@academicchatter

@eLife

I've been through this "consultation" sequence several times. In my experience, it is useless and a waste. Particularly since the whole point of #eLife is post-publication review (the paper is already out in a preprint by definition using the eLife system).

For post-publication peer-review, there is no issue about being slow. Slow is fine. The paper is already available.

Since the authors decide when the paper is "in its final form", there is no issue about suggestions for extra work.

#eLife needs to stand by their decision to do post-publication peer review. They are not a "gate-keeping journal". That's fine. (It's actually good for the role they are playing.)

#peerReview #sciencePublishing

@eLife

I've been through this "consultation" sequence several times. In my experience, it is useless and a waste. Particularly since the whole point of #eLife is post-publication review (the paper is already out in a preprint by definition using the eLife system).

For post-publication peer-review, there is no issue about being slow. Slow is fine. The paper is already available.

Since the authors decide when the paper is "in its final form", there is no issue about suggestions for extra work.

#eLife needs to stand by their decision to do post-publication peer review. They are not a "gate-keeping journal". That's fine. (It's actually good for the role they are playing.)

#peerReview #sciencePublishing

Publishing with eLife: “authors have a lot of control in the publication process”

"Meike van der Heijden, assistant professor at the Fralin Biomedical Research Institute at Virginia Tech Carilion and School of Neuroscience at Virginia Tech, about her latest research and why she chose to publish in the eLife Model"

https://elifesciences.org/inside-elife/0eb2973e/publishing-with-elife-authors-have-a-lot-of-control-in-the-publication-process

#neuroscience #eLife #ScientificPublishing

Publishing with eLife: “authors have a lot of control in the publication process”

"Meike van der Heijden, assistant professor at the Fralin Biomedical Research Institute at Virginia Tech Carilion and School of Neuroscience at Virginia Tech, about her latest research and why she chose to publish in the eLife Model"

https://elifesciences.org/inside-elife/0eb2973e/publishing-with-elife-authors-have-a-lot-of-control-in-the-publication-process

#neuroscience #eLife #ScientificPublishing

Following up on the #eLife / #Clarivate saga, DORA has posted a statement:
https://sfdora.org/2024/11/25/clarivates-actions-regarding-elife-doras-response/

extracts:

"This development reinforces how a commercial entity such as Clarivate, can, through its ownership of scholarly databases and indices, hold the academic community to ransom. Clarivate’s announcement is disappointing as it both punishes innovation in peer review and disregards the important role of authors in deciding how and where their research should be published."

"As funders and institutions increasingly move away from using single metrics to assess research(ers), the role of Journal Impact Factors is becoming increasingly irrelevant."

"We therefore support eLife and encourage it to continue its innovation and encourage other journals to consider doing the same."

Go #eLife, Go AWAY #ImpactFactor!

#Academia #Publication #ScientificPublishers

Following up on the #eLife / #Clarivate saga, DORA has posted a statement:
https://sfdora.org/2024/11/25/clarivates-actions-regarding-elife-doras-response/

extracts:

"This development reinforces how a commercial entity such as Clarivate, can, through its ownership of scholarly databases and indices, hold the academic community to ransom. Clarivate’s announcement is disappointing as it both punishes innovation in peer review and disregards the important role of authors in deciding how and where their research should be published."

"As funders and institutions increasingly move away from using single metrics to assess research(ers), the role of Journal Impact Factors is becoming increasingly irrelevant."

"We therefore support eLife and encourage it to continue its innovation and encourage other journals to consider doing the same."

Go #eLife, Go AWAY #ImpactFactor!

#Academia #Publication #ScientificPublishers

Web of Science can't handle innovation 🤷‍♂️ https://rossmounce.co.uk/2024/11/18/web-of-science-cant-handle-innovation/

#eLife #Clarivate #PRCmodel #Journalology

Web of Science can't handle innovation 🤷‍♂️ https://rossmounce.co.uk/2024/11/18/web-of-science-cant-handle-innovation/

#eLife #Clarivate #PRCmodel #Journalology

This is how I feel about Web of Science vs. eLife fwiw

It's much bigger than just eLife. Clarivate isn't moving with the times.

Many of the best venues you can publish your research in are now _outside_ of Clarivate's "Master Journal List" 🤷‍♂️

eLife transitioning into life beyond Clarivate is part of a much wider trend.

#OpenAccess #AcademicPublishing #eLife #Clarivate #WebOfScience

This is how I feel about Web of Science vs. eLife fwiw

It's much bigger than just eLife. Clarivate isn't moving with the times.

Many of the best venues you can publish your research in are now _outside_ of Clarivate's "Master Journal List" 🤷‍♂️

eLife transitioning into life beyond Clarivate is part of a much wider trend.

#OpenAccess #AcademicPublishing #eLife #Clarivate #WebOfScience

funny to see this over at Clarivate.

Does deleting eLife from the "Master Journal List" really require them to take down the whole thing whilst they do it?

[edit: it's back-up now]

https://mjl.clarivate.com/

#eLife #Clarivate #WebOfScience

funny to see this over at Clarivate.

Does deleting eLife from the "Master Journal List" really require them to take down the whole thing whilst they do it?

[edit: it's back-up now]

https://mjl.clarivate.com/

#eLife #Clarivate #WebOfScience

I think Clarivate puts more faith in peer review than they maybe should. If I read two papers, one published with all the peer reviews public for me to consider versus another paper where the peer review is private but the paper has "passed" the journal's peer review process (whatever that is), I'm no more likely to trust the paper that "passed".

Open-access journal #eLife will lose its ‘impact factor’ over controversial publishing model: https://www.science.org/content/article/web-science-index-plans-end-elife-s-journal-impact-factor

#Academia #PeerReview

I think Clarivate puts more faith in peer review than they maybe should. If I read two papers, one published with all the peer reviews public for me to consider versus another paper where the peer review is private but the paper has "passed" the journal's peer review process (whatever that is), I'm no more likely to trust the paper that "passed".

Open-access journal #eLife will lose its ‘impact factor’ over controversial publishing model: https://www.science.org/content/article/web-science-index-plans-end-elife-s-journal-impact-factor

#Academia #PeerReview

I am consistently blown away at the breadth and depth of expertise that transpires from eLife reviews, and from the many comments in the internal discussion forums that authors don't get to see. For scientists by scientists – it works.

Yes, sometimes it takes time: it's scientists, we are all overcommitted. Yes, sometimes a manuscript isn't sent out for review, because we didn't understand it, or because we deem ourselves not expert in the field and not capable of doing it justice. But overall, it's amazing.

#ScientificPublishing #eLife #PeerReview

I am consistently blown away at the breadth and depth of expertise that transpires from eLife reviews, and from the many comments in the internal discussion forums that authors don't get to see. For scientists by scientists – it works.

Yes, sometimes it takes time: it's scientists, we are all overcommitted. Yes, sometimes a manuscript isn't sent out for review, because we didn't understand it, or because we deem ourselves not expert in the field and not capable of doing it justice. But overall, it's amazing.

#ScientificPublishing #eLife #PeerReview

We should all try to give post-publication or post-rejection feedback there, I think it's really useful! Journals keep judging us, it's our turn to judge them ✊

Example for some journals:
#JournalOfNeuroscience : https://scirev.org/reviews/journal-of-neuroscience/

#eLife: https://scirev.org/reviews/elife/

#PLoSBiology: https://scirev.org/reviews/plos-biology/

#PLoSCompBiol : https://scirev.org/reviews/plos-computational-biology/

#Science : https://scirev.org/reviews/science/

We should all try to give post-publication or post-rejection feedback there, I think it's really useful! Journals keep judging us, it's our turn to judge them ✊

Example for some journals:
#JournalOfNeuroscience : https://scirev.org/reviews/journal-of-neuroscience/

#eLife: https://scirev.org/reviews/elife/

#PLoSBiology: https://scirev.org/reviews/plos-biology/

#PLoSCompBiol : https://scirev.org/reviews/plos-computational-biology/

#Science : https://scirev.org/reviews/science/